The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349.
Get full access to this article
View all access options for this article.
References
1.
BressaG.M.S-adenosyl-l-methionine (SAMe) as antidepressant: Meta-analysis of clinical studies. Acta Neurol Scand.1994; 154(suppl): 7–14.
2.
BaldessariniR.J.Neuropharmacology of S-adenosyl-L-methionine. Am J Med.1987; 83(suppl 5A): 95–103.
3.
VahoraS.A., Malek-AhmadiP.S-adenosylmethionine in the treatment of depression. Neurosci Biobehav Rev.1988; 12: 139–41.
4.
MaccagnoA., Di GiorgioE.E., CastonO.L.Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med.1987; 83(suppl 5A): 72–7.
5.
BellK.M., PlonL., BunneyW.E.JrS-adenosylmethionine treatment of depression: A controlled clinical trial. Am J Psychiatry.1988; 145: 1110–4.
6.
KaganB.L., SultzerD.L., RosenlichtN.Oral S-adenosylmethionine in depression: A randomized, double-blind, placebo-controlled trial. Am J Psychiatry.1990; 147: 591–5.
7.
IruelaL.M., MinguezL., MerinoJ.Toxic interaction of S-adenosylmethionine and clomipramine [letter]. Am J Psychiatry.1993; 150: 522.
8.
BergerR., NowakH.A new medical approach to the treatment of osteoarthritis. Report of an open phase IV study with ademetiontine (Gumbaral). Am J Med.1987; 83(suppl 5A): 84–8.
9.
NicastriP.L., DiaferiaA., TartagniM.A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosyl-methionine in the treatment of intrahepat-ic cholestasis of pregnancy. Br J Obstet Gynecol.1998; 105: 1205–7.
10.
BellK.M., PotkinS.G., CarreonD.S-adenosylmethionine blood levels in major depression: Changes with drug treatment. Acta Neurol Scand.1994; 154(suppl): 15–8.
11.
BottiglieriT., GodfreyP., FlynnT.Cerebrospinal fluid S-adenosylmethion-ine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry.1990; 53: 1096–8.
12.
CarusoI., PietrograndeV.Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. Am J Med.1987; 83(suppl 5A): 66–71.
13.
DomljanZ., VrhovacB., DurriglT.A double-blind trial of ademetionine vs naproxen in activated gonarthrosis. Int J Clin Pharmacol Ther Toxicol.1989; 27: 329–33.
14.
Muller-FassbenderH.Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis. Am J Med.1987; 83(suppl 5A): 81–3.
15.
VetterG.Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med.1987; 83(suppl 5A): 78–80.
16.
KonigB.A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med.1987; 83(suppl 5A): 89–94.
17.
TavoniA., VitaliC., BombardieriS.Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study. Am J Med.1987; 83(suppl 5A): 107–10.%%
18.
ChawlaR.K., BonkovskyH.L., GalambosJ.T.Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs.1990; 40(suppl 3): 98–110
